NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Lodestone moves into retail market
Editor's Picks

Lodestone moves into retail market

The move is aimed at commercial and industrial customers for now.

Ian Llewellyn 17 Apr 2025
The cost of over-regulated banking: $10b to $14.4b a year
Finance

The cost of over-regulated banking: $10b to $14.4b a year

Critics claim a huge annual cost from 30 years of regulatory creep.

Pattrick Smellie 16 Apr 2025
Flexibility is ‘core’ to drivers: Australasian Uber chief
Retail

Flexibility is ‘core’ to drivers: Australasian Uber chief

Emma Foley says drivers want to be contractors, despite the court case opposing it.

Gregor Thompson 15 Apr 2025
Blackbull backs Eden Bradfield into Elevation funds
Finance

Blackbull backs Eden Bradfield into Elevation funds

The Christopher Swasbrook-established fund gets new investors and portfolio manager.